FDA accepts TG Therapeutics' application for ublituximab + ukoniq in blood cancer
May 25 2021 - 7:20AM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
TG Therapeutics (NASDAQ:TGTX)
Historical Stock Chart
From Mar 2024 to Apr 2024
TG Therapeutics (NASDAQ:TGTX)
Historical Stock Chart
From Apr 2023 to Apr 2024